摘要
虽然介入治疗可以解除肾动脉狭窄,但粥样硬化性性肾动脉狭窄介入治疗的最佳时机尚不明确。该文从肾动脉狭窄介入治疗现状、专家共识和治疗策略转变三个方面进行综述,认为合并一过性肺水肿、全肾缺血、难治性高血压及肾功能快速减退的高危肾动脉狭窄患者可以从介入治疗中获益。
Although revascularization can relieve renal artery obstruction anatomically,the best time of revascularization is not clear for atherosclerotic renal artery stenosis(ARAS).In this review,we evaluate the existing evidence and offer an approach to the management about ARAS.From the data achieved those with a hemodynamically significant ARAS in the context of Flash pulmonary edema,whole renal ischemia,refractory hypertension and/or deteriorating renal insufficiency rapidly,interventional therapy seems to be clinical benefit from revascularization.
作者
艾虎
唐国栋
孙福成
Ai Hu;Tang Guodong;Sun Fucheng(Department of Cardiology,Beijing Hospital,National Center of Gerontology,Institute of Geriatrics Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China)
出处
《中国临床保健杂志》
CAS
2020年第6期848-850,共3页
Chinese Journal of Clinical Healthcare
关键词
肾动脉梗阻
动脉粥样硬化
血管内操作
综述
Renal artery obstruction
Atherosclerosis
Endovascular procedures
Review
